Brief: Pegbio Co Enters MoU With Rani Therapeutics
10/07/2026 02:25
BRIEF-Pegbio Co Enters MoU With Rani Therapeutics July 10 (Reuters) - PegBio Co Ltd 2565.HK:
ENTERS MOU WITH NASDAQ-LISTED RANI THERAPEUTICS
COLLABORATION TO ADVANCE ORAL DELIVERY OF MULTIPLE METABOLIC ASSETS
Further company coverage: 2565.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pegbio
See all newsBrief: Pegbio Enters Joint Research And Development Collaboration With SN Bioscience
Brief: Alibaba Health Inks Strategic Tie-Up With Tenry, PegBio To Launch GLP-1RA Drug
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: PegBio Co Posts FY Loss Attributable RMB208.4 Million
PegBio jumps most in 7 months on deal with Shanghai Tenry